Coronavirus treatment – Tiziana Life Sciences files patent

Tiziana Life Sciences files patent for novel Coronavirus treatment technology via inhaled delivery

globenewswire

Tiziana Life Sciences has filed a patent for the direct delivery method of anti-IL-6 receptor (anti-IL-6R) monoclonal antibodies (mAbs) which is passed into the lungs using a handheld inhaler or nebulizer. This method is used to treat COVID-19 infections and also be applicable for uses with other FDA approved mAbs and drugs.

Apple files patent for a novel charging method

phonearena

Apple files a patent for a novel charging technology. The technology described in the patent relates not to a wireless charger but for a way for Apple devices to charge one another. Using this technology it is possible to charge laptop, phone, earbuds, and smartwatch by a single MacBook charger.

Valve patents new Steam Controller

techradar

The recently published patent of Valve shows a new version of a steam controller. The controller explained in the patent allows the dynamic swapping of controls for changing the configuration of the controller to meet the needs of different applications.

Huawei files patent for the design of a new smart speaker

gizbot

Huawei recently filed a design patent for a new smart speaker. The patent shows a design with the front side of the smart speaker which houses the power button and the volume controls. This speaker is likely to support the Huawei voice assistant – Celia

Ford’s new patent application helps to sniff out stinky ride-hailing cars

cnet

Ford has filed a patent application for a technology that helps to sniff out stinky ride-hailing cars. The system disclosed in the patent application uses an environmental sensor that allows a user to pick the smells which bug them and set thresholds accordingly.

BriaCell files Coronavirus Immunotherapy Patent

globenewswire

BriaCell Therapeutics Corp. has filed a patent for genetically engineered whole-cell immunotherapy which is used to treat certain infectious diseases like the SARS-CoV-2 virus that causes COVID-19.

Orthogonal Thinker files patent for a proprietary psilocybin product

benzinga

Orthogonal Thinker, a biotechnology-based company has filed a patent for a psilocybin product. The molecule of the psilocybin is developed to be true to the essence of psilocybin mushrooms and the legacy of psychedelic science.

Coronavirus saliva test developed by Rutgers gets FDA approval

CNBC

Rudgers has developed a coronavirus saliva test. This test helps the people who are in quarantine to confirm the coronavirus affected persons and reduces the risk of getting close to a patient and possibly becoming infected, during collection.

Related post: NEED ATTENTION on INACTIVE Status – Flexible Electronics